Concepedia

Mitchell T. Ferguson

MT

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mitchell T. Ferguson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in neuroscience, medicine, and memory.

Publications per year

2009–2011

3

Publications

3

Prefrontal cortex lesions and scopolamine impair attention performance of C57BL/6 mice in a novel 2-choice visual discrimination task

Gregory M. Dillon, Delia S. Shelton, Ailbhe McKinney et al. · Behavioural Brain Research · 2009 · 31 citations

, , +15

Isoform‐specific effects of apolipoprotein E on cognitive performance in targeted‐replacement mice overexpressing human APP

Thomas Kornecook, Ailbhe McKinney, Mitchell T. Ferguson et al. · Genes Brain & Behavior · 2009 · 29 citations · Full text

, , +17

MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice

Gregory M. Dillon, Laura S. Lubbers, Mitchell T. Ferguson et al. · Behavioural Pharmacology · 2011 · 12 citations

, , +15

1–3 of 3